Title | Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification. |
Publication Type | Journal Article |
Year of Publication | 2002 |
Authors | Ghigo E, Capo C, Aurouze M, Tung C-H, Gorvel J-P, Raoult D, Mege J-L |
Journal | Infect Immun |
Volume | 70 |
Issue | 3 |
Pagination | 1501-6 |
Date Published | 2002 Mar |
ISSN | 0019-9567 |
Keywords | Acids, Actinobacteria, Antigens, CD, Cathepsin D, HeLa Cells, Humans, Hydrogen-Ion Concentration, Lysosome-Associated Membrane Glycoproteins, Lysosomes, Membrane Fusion, Membrane Glycoproteins, Phagosomes, Vacuoles, Whipple Disease |
Abstract | Tropheryma whipplei was established as the agent of Whipple's disease in 2000, but the mechanisms by which it survives within host cells are still unknown. We show here that T. whipplei survives within HeLa cells by controlling the biogenesis of its phagosome. Indeed, T. whipplei colocalized with lysosome-associated membrane protein 1, a membrane marker of late endosomal and lysosomal compartments, but not with cathepsin D, a lysosomal hydrolase. This defect in phagosome maturation is specific to live organisms, since heat-killed bacilli colocalized with cathepsin D. In addition, T. whipplei survived within HeLa cells by adapting to acidic pH. The vacuoles containing T. whipplei were acidic (pH 4.7 +/- 0.3) and acquired vacuolar ATPase, responsible for the acidic pH of late phagosomes. The treatment of HeLa cells with pH-neutralizing reagents, such as ammonium chloride, N-ethylmaleimide, bafilomycin A1, and chloroquine, increased the intravacuolar pH and promoted the killing of T. whipplei. The ability of T. whipplei to survive in an acidic environment and to interfere with phagosome-lysosome fusion is likely critical for its prolonged persistence in host cells during the course of Whipple's disease. Our results suggest that manipulating the intravacuolar pH may provide a new approach for the treatment of Whipple's disease. |
DOI | 10.1128/IAI.70.3.1501-1506.2002 |
Alternate Journal | Infect Immun |
PubMed ID | 11854238 |
PubMed Central ID | PMC127739 |
Related Institute:
Molecular Imaging Innovations Institute (MI3)